World's Smallest Skin Cancer; Exercise Boosts Immune Cells; Cannabis and Pain Relief

[MEDPAGE TODAY]( Oncology Update Friday, May 05, 2023 [World's Smallest Skin Cancer; Exercise Boosts Immune Cells; Cannabis and Pain Relief]( [Implanted Ultrasound Device Opening Blood-Brain Barrier Promising in Brain Tumors]( [Food 'Swamps' Tied to Elevated Mortality From Obesity-Related Cancers]( [Mysterious White Blood Cell Disorder Not Just 'AIDS Without HIV']( ['Fantastic,' 'Terrific' Results With Oncolytic Virus Combo for Bladder Cancer]( ADVERTISEMENT Exclusives & Features [New Report Warns of Medical Credit Cards, Loans Pushed on Patients]( [Series Documents How Nurses Experience Racism]( [Seattle Physician Dies Climbing Mount Everest]( [After early-stage breast cancer, interrupting endocrine therapy to become pregnant didn’t raise risk of recurrence]( After early-stage breast cancer, women can pause taking endocrine therapy to become pregnant without an increased risk of recurrence, a new study finds. [READ MORE]( [NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.]( BACKGROUND: PD-1/PD-L1 inhibitors have improved survival for patients with non-small cell lung cancer (NSCLC). We evaluated natural killer cell activity (NKA) and methylated HOXA9 circulating tumor... [READ MORE]( [A nested case-control study of untargeted albumin adductomics and acute myeloid leukemia.]( Environmental exposures often produce reactive electrophiles in vivo, leading to oxidative stress, which plays a major role in carcinogenesis. These electrophiles frequently form adducts with human... [READ MORE]( [LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection.]( PURPOSE: This study aimed to explore the association of preoperative magnetic resonance imaging (MRI) tumor morphological classification with early recurrence (ER) and overall survival (OS) after... [READ MORE]( [Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.]( BACKGROUND: Before 2018, there was no standard of care for non-metastatic (M0) castration resistant prostate cancer nmCRPC. Androgen receptor antagonists (ARAs) were commonly used sequentially... [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-05-05&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011